Literature DB >> 26445305

Intensive Care Unit Admission With Community-Acquired Pneumonia.

Adam S Vohra1, Hyo Jung Tak, Maulin B Shah, David O Meltzer, Gregory W Ruhnke.   

Abstract

BACKGROUND: There has been a dramatic increase in the use of intensive care units (ICUs) over the past 25 years. Greater use of validated measures of illness severity may better inform ICU admission decisions in patients with community-acquired pneumonia. This article examined predictors of ICU admission and hospitalization costs, including the pneumonia severity index (PSI) and CURB-65 (confusion, uremia, respiratory rate, blood pressure, age ≥65 years) scores.
METHODS: The study identified 422 patients hospitalized for community-acquired pneumonia, ascertaining patient characteristics by chart review and extraction of administrative data. Multivariate logistic regression was performed to quantify the association of the PSI, CURB-65 and comorbidities with ICU admission. The predictors of cost were estimated using a generalized linear model.
RESULTS: Compared to 194 general medicine patients, certain clinical and radiographic findings were more common among 228 ICU patients. Compared to PSI reference group I/II/III, ICU admission was strongly associated with risk class IV (odds ratio [OR], 3.06; 95% confidence interval [CI], 1.63-5.72) and V (OR, 4.84; CI, 2.44-9.62), and also CURB-65 ≥3 (OR, 2.90; CI, 1.51-5.56). The relative increase in mortality among PSI risk class V (compared to IV) patients was 2.68 times higher in general medicine, compared with the ICU. Among ICU admissions, risk class V was associated with an additional cost of $14,548 (95% CI, $4,232 to $24,864).
CONCLUSIONS: Illness severity and chronic pulmonary disease are strong predictors of ICU admission. More extensive use of the PSI may optimize site-of-care decisions, thereby minimizing mortality and unnecessary resource utilization.

Entities:  

Mesh:

Year:  2015        PMID: 26445305     DOI: 10.1097/MAJ.0000000000000568

Source DB:  PubMed          Journal:  Am J Med Sci        ISSN: 0002-9629            Impact factor:   2.378


  5 in total

1.  Fatty acid-binding proteins as biomarkers of disease severity and outcome in community-acquired pneumonia.

Authors:  Charles Feldman; Ronald Anderson
Journal:  Ann Transl Med       Date:  2016-10

2.  Fatty acid binding proteins as biomarkers of disease severity and response to treatment in severe pneumonia required admission to intensive care unit.

Authors:  Han-Chen Tsai; Shi-Chuan Chang
Journal:  Ann Transl Med       Date:  2016-10

3.  A new prediction model for assessing the clinical outcomes of ICU patients with community-acquired pneumonia: a decision tree analysis.

Authors:  Shufang Zhang; Kai Zhang; Yang Yu; Baoping Tian; Wei Cui; Gensheng Zhang
Journal:  Ann Med       Date:  2019-03-23       Impact factor: 4.709

4.  The Relative Ability of Comorbidity Ascertainment Methodologies to Predict In-Hospital Mortality Among Hospitalized Community-acquired Pneumonia Patients.

Authors:  Ronald E Weir; Christopher S Lyttle; David O Meltzer; Tien S Dong; Gregory W Ruhnke
Journal:  Med Care       Date:  2018-11       Impact factor: 2.983

5.  The Impact of Principal Diagnosis on Readmission Risk among Patients Hospitalized for Community-Acquired Pneumonia.

Authors:  Gregory W Ruhnke; Peter K Lindenauer; Christopher S Lyttle; David O Meltzer
Journal:  Am J Med Qual       Date:  2022-01-11       Impact factor: 1.200

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.